179 results
Page 5 of 9
8-K
EX-99.1
jr4t0sivl1g 9sdp4
15 Aug 22
Ra Medical Systems Reports Second Quarter 2022 Financial Results
5:49pm
8-K
azd9z v8nubll9t2
22 Jul 22
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
wxk1nmh6 jx
22 Jul 22
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
fhi2qr 54h8mwqtyvv5c
18 Jul 22
Ra Medical Systems Appoints Brian D. Conn Interim Chief Financial Officer
4:15pm
POS AM
990gu5j
13 Jul 22
Prospectus update (post-effective amendment)
6:13am
8-K
EX-99.1
a01qp6c232238r
8 Jul 22
Ra Medical Systems Receives FDA 510(k) Clearance for the DABRA 2.0 Catheter
4:23pm
8-K
4ecpt tv6sdbphht0e
6 Jun 22
Cost Associated with Exit or Disposal Activities
4:36pm
8-K
EX-99.1
52wtw7
16 May 22
Ra Medical Systems Reports First Quarter 2022 Financial Results
4:28pm
8-K
EX-99.1
4xdkmkh
23 Mar 22
Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results
4:21pm
8-K
EX-99.1
1easm2ve kcm16
9 Feb 22
Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering
12:00am
8-K
EX-1.1
a4u6lzz
9 Feb 22
Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering
12:00am
424B1
x0k o0u69gxw7i87j
7 Feb 22
Prospectus with pricing info
6:02am
FWP
w6v6mbt610hhl 94
28 Jan 22
Free writing prospectus
6:03am
FWP
7cokee9xxei2i4
20 Jan 22
Free writing prospectus
6:59am